Evaluating the UnityPhilly Overdose Response App for Preventing Opioid Overdoses and Supporting Community Safety in Philadelphia

What this Trial Is About

Researchers are evaluating the UnityPhilly app, which aims to help citizen responders prevent opioid overdoses in Philadelphia. This behavioral clinical trial focuses on how different groups of people use the app to signal overdoses and respond with naloxone, a medication that can reverse overdoses. The study includes people who use opioids non-medically, those on prescription opioids, individuals in recovery, caregivers, and concerned community members to understand app effectiveness in various settings. All participants will receive training on how to use the UnityPhilly app and respond to overdoses with naloxone. The study enrolls 450 participants over 9 months from three Philadelphia neighborhoods, who will use the app and be followed for 12 months to measure outcomes such as overdose signaling and response rates. Additionally, 3,000 resident volunteers will download and use the app over two years to assess its sustainability and community reach. Participants will be involved in training, using the app, and completing follow-up surveys about their experiences. Data collected includes app usage logs, survey responses, and interviews to evaluate how well the app helps prevent overdoses and how widely it is adopted. The study will measure the rates of overdoses signaled and reversed over two years, with ongoing assessments to understand the apps long-term impact and effectiveness.

UnityPhilly Response App for Overdose Reversal